Skip to main content
logo
First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
47.90
+2.47 (5.44%)
At close: Nov 6, 2026, 4:00 PM EST
47.00
-0.90 (-1.88%)
After-hours: Nov 6, 2026, 7:56 PM EST

TRAX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Net Income
-149.8-166.09-163.71-106.15
Depreciation & Amortization
1.932.422.42.38
Loss (Gain) From Sale of Investments
-0.2-4.73-10.31-10.52
Stock-Based Compensation
35.7732.326.8318.39
Change in Accounts Payable
13.39-5.3117.818.39
Change in Other Net Operating Assets
-11.22-1.521.18-5.49
Operating Cash Flow
-110.12-142.93-125.81-93
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.04-0.09-0.36-0.81
Investment in Securities
108.5228.1295.76145.56
Investing Cash Flow
108.46228.0395.4144.75

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
321.7230.01117.52-
Other Financing Activities
-274.26---87.09
Financing Cash Flow
47.4630.01117.52-87.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
45.79115.1287.12-35.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-110.17-143.01-126.16-93.81
Free Cash Flow Growth
----
Levered Free Cash Flow
--82.76-63.42-
Unlevered Free Cash Flow
--82.76-63.42-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
2.18-6.8318.992.9